Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Metlife (MET) over the last 17 years, with Q3 2025 value amounting to $308.0 million.

  • Metlife's Gains from Investment Securities rose 1039.43% to $308.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 1077.54%. This contributed to the annual value of $1.6 billion for FY2024, which is 1271.14% down from last year.
  • Metlife's Gains from Investment Securities amounted to $308.0 million in Q3 2025, which was up 1039.43% from $783.0 million recorded in Q2 2025.
  • In the past 5 years, Metlife's Gains from Investment Securities registered a high of $2.2 billion during Q4 2021, and its lowest value of $35.0 million during Q3 2022.
  • Its 5-year average for Gains from Investment Securities is $462.0 million, with a median of $308.0 million in 2025.
  • As far as peak fluctuations go, Metlife's Gains from Investment Securities tumbled by 7972.6% in 2022, and later surged by 57428.57% in 2023.
  • Over the past 5 years, Metlife's Gains from Investment Securities (Quarter) stood at $2.2 billion in 2021, then tumbled by 79.73% to $444.0 million in 2022, then increased by 8.33% to $481.0 million in 2023, then tumbled by 32.02% to $327.0 million in 2024, then decreased by 5.81% to $308.0 million in 2025.
  • Its Gains from Investment Securities stands at $308.0 million for Q3 2025, versus $783.0 million for Q2 2025 and $147.0 million for Q1 2025.